Worldwide experience with lymphatic mapping for invasive breast cancer

Seminars in Oncology

Volumn 31, Issue 3, 2004, Pages 318-323

  Pendas, Solange ^a   Giuliano, Rosemary ^a   Swor, Gray ^a   Gardner, Mary ^a   Jakub, James ^a   Reintgen, Douglas S ^a  

^a Lakeland Regional Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; TECHNETIUM 99M; TRACER;

AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EXPERIENCE; GENE MAPPING; HUMAN; INTERNAL MAMMARY ARTERY; LYMPH NODE DISSECTION; MAMMARY GLAND; METASTASIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; TECHNIQUE; UNIVERSITY HOSPITAL;

EID: 3042716060     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2004.03.013     Document Type: Article

References (18)

1. Dowlatshahi K., Fan M., Snider H.C. Lymph node micrometastases from breast carcinoma. Reviewing the dilemma. Cancer. 80:1997;1188-1197
2. Cox C.E. Lymphatic mapping in breast cancer Combination technique. Third International Sentinel Node Congress. K10-1:2002;140. (abstr)
3. Cox C., Pendas S., Cox J., et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 227:1998;645
4. McCarter M.D., Yeung H., Cody H.S. III, et al. Localization of the sentinel node in breast cancer Identical results with same-day and day-before isotope injection. Ann Surg Oncol. 8:2001;682-686
5. Kern K.A. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg. 189:1999;539-545
6. Giuliano A.E., Jones R.C., Brennan M., et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 15:1997;2345-2350
7. Guenther J.M., Krishnamoorthy M., Tan L.R. Sentinel lymphadenectony for breast cancer in a community managed care setting. Cancer J Sci Am. 3:1997;336-340
8. Flett M.M., Going J.J., Stanton P.D., et al. Sentinel node localization in patients with breast cancer. Br J Surg. 85:1998;991-993
9. Kern K.A. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar infecjection of blue dye and technetium 99m sulfur colloid. J Am Coll Surg. 195:2002;467-475
10. Langer I., Zuber M., Oertli D., et al. Axillary recurrence rate after sentinel lymph node biopsy in invasive breast cancer patients. Third International Sentinel Node Congress. 86:2002;175. (abstr)
11. Blanchard D.K., Donohue J.H., Reynolds C., et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg. 138:2003;482-488
12. Giuliano A.E., Haigh P.I., Brennan M.B., et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 18:2000;2553-2559
13. van der Ent F.W.C, Sittard M., et al. Routine internal mammary sentinel node biopsy in breast cancer Results and clinical implications. The Third International Sentinel Node Congress. 89:2002;176. (abstr)
14. Gomez K., Mansel R.E. How important are the internal mammary nodes within the sentinel node experience? Third International Sentinel Node Congress. P69:2002;203. (abstr)
15. Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer. 73:1994;505
16. Morrow M. Role of axillary dissection in breast cancer management. Ann Surg Oncol. 3:1996;233
17. Baxter N., McCready D., Chapman J.A., et al. Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer. Ann Surg Oncol. 3:1996;235
18. Wong S.L., Chao C., McMasters K.M., et al. Frequency of sentinel lymph node metastases in patients with favorable breast cancer histologic subtypes. Am J Surgery. 184:2002;492-498